Olga Lesnyak1, Alla Zakroyeva2, Varta Babalyan3, Victor Cazac4, Gulzhan Gabdulina5, Said Ismailov6, Olga Lobanchenko7, Ema Rudenka8, Marina Tsagareli9, Helena Johansson10, Nickolas C Harvey11, Eugene McCloskey12, John A Kanis10,12. 1. North West State Medical University named after Mechnikov, St. Petersburg, Russian Federation. olga.m.lesnyak@yandex.ru. 2. Ural State Medical University, Yekaterinburg, Russian Federation. 3. Osteoporosis Center, Yerevan, Armenia. 4. State University of Medicine and Pharmacy, Chisinau, Republic of Moldova. 5. Asfendiyarov National Medical University, Almaty, Kazakhstan. 6. Tashkent Medical Pediatric Institute, Tashkent, Uzbekistan. 7. Kyrgyz State Medical Academy, Bishkek, Kyrgyz Republic. 8. Belarusian State Medical University, Minsk, Belarus. 9. National Institute of Endocrinology, Tbilisi, Georgia. 10. Mary McKillop Institute for Health Research, Catholic University of Australia, Melbourne, Australia. 11. MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK. 12. Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
Abstract
Age-specific intervention and assessment thresholds based on FRAX® were developed for eight Eurasian countries participating in the EVA study (Armenia, Belarus, Georgia, Moldova, Kazakhstan, the Kyrgyz Republic, the Russian Federation, and Uzbekistan). The intervention thresholds (major osteoporotic fracture) ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for people at age 50 years, and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. These thresholds enable a substantial advance in the ease of detection of individuals at high fracture risk. INTRODUCTION: The purpose of this study was to derive and compare FRAX-based intervention and BMD assessment thresholds for 8 Eurasian countries in the EVA study. METHODS: The intervention threshold (IT) was set at a 10-year probability of a major osteoporotic fracture (MOF), calculated without BMD, equivalent to a woman with a prior fragility fracture but no other clinical risk factors, and a body mass index (BMI) of 25.0 kg/m2. The lower assessment threshold was set at a 10-year probability of a MOF in women with BMI of 25.0 kg/m2, without previous fracture or other clinical risk factors. The upper assessment threshold was set at 1.2 times the IT. RESULTS: The age-specific intervention thresholds ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for men and women at the age of 50 years and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. The difference between countries was most evident at younger ages and become progressively less with advancing age. CONCLUSIONS: For the 8 Eurasian countries, the newly established FRAX-based intervention thresholds provide an opportunity to improve the clinical detection of both men and women with a high risk of fracture and improve treatment rates.
Age-specific intervention and assessment thresholds based on FRAX® were developed for eight Eurasian countries participating in the EVA study (Armenia, Belarus, Georgia, Moldova, Kazakhstan, the Kyrgyz Republic, the Russian Federation, and Uzbekistan). The intervention thresholds (major osteoporotic fracture) ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for people at age 50 years, and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. These thresholds enable a substantial advance in the ease of detection of individuals at high fracture risk. INTRODUCTION: The purpose of this study was to derive and compare FRAX-based intervention and BMD assessment thresholds for 8 Eurasian countries in the EVA study. METHODS: The intervention threshold (IT) was set at a 10-year probability of a major osteoporotic fracture (MOF), calculated without BMD, equivalent to a woman with a prior fragility fracture but no other clinical risk factors, and a body mass index (BMI) of 25.0 kg/m2. The lower assessment threshold was set at a 10-year probability of a MOF in women with BMI of 25.0 kg/m2, without previous fracture or other clinical risk factors. The upper assessment threshold was set at 1.2 times the IT. RESULTS: The age-specific intervention thresholds ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for men and women at the age of 50 years and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. The difference between countries was most evident at younger ages and become progressively less with advancing age. CONCLUSIONS: For the 8 Eurasian countries, the newly established FRAX-based intervention thresholds provide an opportunity to improve the clinical detection of both men and women with a high risk of fracture and improve treatment rates.
Authors: Olga Lesnyak; Olga Ershova; Ksenia Belova; Elena Gladkova; Olga Sinitsina; Olga Ganert; Marina Romanova; Vitalij Khodirev; Helena Johansson; Eugene McCloskey; John A Kanis Journal: Arch Osteoporos Date: 2012-05-09 Impact factor: 2.617
Authors: John A Kanis; Olof Johnell; Anders Oden; Frederik Borgstrom; Helena Johansson; Chris De Laet; Bengt Jönsson Journal: Osteoporos Int Date: 2004-04-22 Impact factor: 4.507
Authors: J Compston; A Cooper; C Cooper; R Francis; J A Kanis; D Marsh; E V McCloskey; D M Reid; P Selby; M Wilkins Journal: Maturitas Date: 2009-01-08 Impact factor: 4.342
Authors: H Ramanau; I Chernyanin; E Rudenka; O Lesnyak; A Zakroyeva; J P Bilezikian; H Johansson; N C Harvey; E V McCloskey; J A Kanis Journal: Arch Osteoporos Date: 2018-04-17 Impact factor: 2.617
Authors: O Lesnyak; S Ismailov; M Shakirova; N Alikhanova; A Zakroyeva; L Abboskhujaeva; H Johansson; N C Harvey; E McCloskey; J A Kanis Journal: Arch Osteoporos Date: 2020-07-29 Impact factor: 2.617
Authors: S Issayeva; O Lesnyak; A Zakroyeva; B Issayeva; D Dilmanova; H Johansson; E Liu; M Lorentzon; N C Harvey; E McCloskey; J A Kanis Journal: Arch Osteoporos Date: 2020-02-27 Impact factor: 2.617
Authors: Alla Zakroyeva; Olga Lesnyak; Victor Cazac; Liliana Groppa; Eugen Russu; Lia Chislari; Larisa Rotaru; Helena Johansson; Nicholas C Harvey; Eugene McCloskey; Mattis Lorentzon; John A Kanis Journal: Arch Osteoporos Date: 2020-01-28 Impact factor: 2.617
Authors: J A Kanis; F Borgström; J Compston; K Dreinhöfer; E Nolte; L Jonsson; W F Lems; E V McCloskey; R Rizzoli; J Stenmark Journal: Arch Osteoporos Date: 2013-09-13 Impact factor: 2.617
Authors: O Lesnyak; S Sahakyan; A Zakroyeva; J P Bilezikian; N Hutchings; V Babalyan; R Galstyan; A Lebedev; H Johansson; N C Harvey; E McCloskey; John A Kanis Journal: Arch Osteoporos Date: 2017-11-07 Impact factor: 2.617
Authors: H Johansson; G Naureen; R Iqbal; L Jafri; A H Khan; M Umer; E Liu; L Vandenput; M Lorentzon; E V McCloskey; J A Kanis; N C Harvey Journal: Osteoporos Int Date: 2021-08-20 Impact factor: 4.507
Authors: P Chotiyarnwong; E V McCloskey; N C Harvey; M Lorentzon; D Prieto-Alhambra; B Abrahamsen; J D Adachi; F Borgström; O Bruyere; J J Carey; P Clark; C Cooper; E M Curtis; E Dennison; M Diaz-Curiel; H P Dimai; D Grigorie; M Hiligsmann; P Khashayar; E M Lewiecki; P Lips; R S Lorenc; S Ortolani; A Papaioannou; S Silverman; M Sosa; P Szulc; K A Ward; N Yoshimura; J A Kanis Journal: Arch Osteoporos Date: 2022-06-28 Impact factor: 2.879